Skip to main content

Web Exclusives

Neoantigens Are Effective Targets for Developing Cancer Vaccines

Head and Neck Cancer, Leukemia

November 4, 2019 — Oncology News & Updates

Disparities in Oncology Care

Oral Parity Laws Could Reduce Disparities in Cancer Care

Clinical Trials

Patient-Centered Clinical Pathways Should Incorporate the Patient’s Voice

Financial Toxicity High for Low-Income Patients in Early-Phase Clinical Trials

FDA Updates

Nubeqa New Oral Therapy FDA Approved for Nonmetastatic Prostate Cancer

FDA Updates

Turalio First FDA-Approved Systemic Therapy for Tenosynovial Giant-Cell Tumor

FDA Updates

Rozlytrek Third FDA-Approved Tumor-Agnostic Drug and Second Treatment for Patients with NTRK Fusion Tumors

Meeting Highlights

Breast Cancer, ESMO Highlights, CDK4/6 Inhibitors

Adding CDK4/6 Inhibitor to Endocrine Therapy Improves Survival in Advanced Breast Cancer: New Standard of Care

Head and Neck Cancer

Oral Cancer and Sex in the Era of HPV Infection

Meg Barbor, MPH

Page 23 of 43
Results 221 - 230 of 425